Although TP53-mutant ES2 cells comprise histologic types of clear cell carcinoma, the expression pattern of phospho-Smad2 and Smad2 by TGF-β induction was significantly reduced following bAP15 treatment. The gene discussed is SMAD2; the disease is clear cell adenocarcinoma.